Clinical Trials

Showing 261 - 280 of 510 trials
Titlesort icon Investigator Disease(s)
A Phase II Study of KW-0761 or Standard Therapy in Patients with Previously Treated Adult T-Cell Leukemia-Lymphoma
[Protocol 12-251]
Horwitz, Steven
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of IZN-6N4 to Reduce Mouth Sores in Patients with Head and Neck Cancer Receiving Chemotherapy and Radiation Therapy
[Protocol 12-204]
Lee, Nancy
  • Head & Neck Cancer
A Phase II Study of Irinotecan and Temozolomide in Combination with Existing High-Dose Chemotherapy for Patients Newly Diagnosed with Ewing Sarcoma
[Protocol 13-068]
Magnan, Heather
  • Sarcomas
    • Ewing's Sarcoma
    • Soft Tissue Sarcoma
A Phase II Study of Ipilimumab Plus Isolated Limb Infusion with Melphalan and Dactinomycin to Treat Advanced Unresectable Melanoma of the Extremity
[Protocol 10-101]
Ariyan, Charlotte
  • Melanoma
A Phase II Study of Ipilimumab in Children and Adolescents with Stage III/IV Inoperable Melanoma
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-043]
Dunkel, Ira
  • Melanoma
A Phase II Study of Intrathecal I131-3F8 in Patients with GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms
[Protocol 05-122]
Kramer, Kim
  • Brain Tumors, Metastatic
  • Brain Tumors, Primary
    • Brain Metastases
  • Neuroblastoma
  • Pediatric Brain Tumors
    • Brain Cancer
    • CNS Cancer
A Phase II Study of Intensity-Modulated Radiation Therapy for the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer
[Protocol 13-070]
Lee, Nancy
  • Head & Neck Cancer
  • Thyroid Cancer
A Phase II Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma
Relapsed/Refractory
[Protocol 12-205]
Chou, Alexander
  • Primary Bone
    • Osteosarcoma
  • Sarcomas
    • Osteosarcoma
A Phase II Study of Ibrutinib in Patients with Persistent or Recurrent Marginal Zone Lymphoma
[Protocol 14-058]
Noy, Ariela
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Hepatic Arterial Infusion with Floxuridine and Dexamethasone plus Systemic Gemcitabine and Oxaliplatin in Patients with Inoperable Intrahepatic Cholangiocarcinoma
[Protocol 13-066]
Jarnagin, William
  • Hepatobiliary
    • Liver Cancer
A Phase II Study of Hepatic Arterial Infusion and Intravenous Chemotherapy with or without Panitumumab in Patients with Normal KRAS with Resected Liver Metastases from Colorectal Cancer
[Protocol 10-137]
Kemeny, Nancy
  • Colorectal Cancer
A Phase II Study of Gemcitabine, Carboplatin, and Panitumumab Given Before Surgery in Patients with Muscle-Invasive Bladder Cancer
[Protocol 10-103]
Bajorin, Dean
  • Bladder Cancer
A Phase II Study of Gemcitabine and Cisplatin before Surgery in Patients with High-Grade Upper Tract Urothelial Carcinoma
[Protocol 10-208]
Coleman, Jonathan
  • Kidney Cancer
A Phase II Study of FOLFOX plus Regorafenib in Patients with Inoperable or Metastatic Esophageal and/or Stomach Cancer
[Protocol 13-080]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Phase II Study of Exemestane with and without Enzalutamide in Women with Advanced Hormone Receptor-Positive Breast Cancer
[Protocol 13-257]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Everolimus, Leuprolide/Letrozole, and Everolimus/Leuprolide/Letrozole in Patients with Inoperable Fibrolamellar Hepatocellular Carcinoma
Newly Diagnosed & Relapsed/Refractory
[Protocol 11-211]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase II Study of Enzalutamide in Patients with Advanced or Recurrent Androgen Receptor-Positive Ovarian Cancer
[Protocol 13-119]
Grisham, Rachel
  • Ovarian Cancer
A Phase II Study of Dose-Dense Doxorubicin and Cyclophosphamide followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer
[Protocol 10-190]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Dose-Adjusted EPOCH Chemotherapy with or without Rituximab in Patients with Untreated Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma, or Plasmablastic Lymphoma
[Protocol 13-022]
Noy, Ariela
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of Docetaxel Alone or with OGX-427 in Patients with Recurrent or Refractory Urothelial Cancers
Relapsed/Refractory
[Protocol 13-127]
Rosenberg, Jonathan
  • Bladder Cancer
  • Kidney Cancer